Company / Assets per Share
Gossamer Bio, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.76
FY2025
5-year range
$0.76 / $4.59
FY2021-FY2025
Trend
-45.7%
vs FY2024
Sector context
#203 of 210
Health Care
What the data says
Among 210 Health Care companies, Gossamer Bio, Inc. is in the bottom 3% for assets per share. Assets per Share has declined for 5 consecutive years, from $7.87 in FY2020 to $0.76 in FY2025.
Based on SEC 10-K filings.
0.76 in FY2025 with a 5-year CAGR of -37.3%.
Declined from $2.04 to $0.76 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -38.2%
- 5-Year CAGR
- -37.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 210This company $0.76 Sector average $353.15
▼
-99.8% below sector average
Key checks
Key Insights
- Gossamer Bio, Inc.'s assets per share has declined for 5 consecutive years.
- In FY2025, assets per share decreased 45.7% year-over-year.
- Ranks #203 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.76 | -45.7% |
| FY2024 | $1.40 | -31.6% |
| FY2023 | $2.04 | -36.6% |
| FY2022 | $3.22 | -29.8% |
| FY2021 | $4.59 | -41.7% |
| FY2020 | $7.87 | +1.0% |
| FY2019 | $7.79 | -78.8% |
| FY2018 | $36.81 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026